Quantcast

Optigenex Inc. Announces Supply And License Agreement With Suracell Inc. To Utilize The AC-11(R) Trademark And Technology For Oral Supplements In The United States, Canada And South Korea

October 21, 2009
    Company plans to market dietary supplements under the brand name Suracell
    with AC-11(R) (Financial terms were not disclosed).

NEW YORK, Oct. 21 /PRNewswire-FirstCall/ – Optigenex Inc. (Pinksheets: OPGX) announced today the signing of a Supply and Trademark License Agreement with Suracell Inc. to provide its patented ingredient AC-11(R) for use in a focused nutritional and age management dietary supplement program. The agreement coupled with Suracell’s marketing plans will provide another platform to introduce Optigenex’s technology under the registered trademark AC-11(R) to health conscious consumers in the United States, Canada and South Korea.

Beginning in January 2010, Suracell will be marketing a specific dietary supplement regimen. Participants will complete lifestyle questionnaires and will be asked to provide specimens for testing of key bio markers that will form the basis for a focused nutritional supplement program utilizing the diverse line of Suracell formulated products with AC-11(R).

All-natural, herbal-extracted and patented AC-11(R) is marketed by over 100 manufacturers and marketing companies in Japan, Europe, the Middle East, the United States and Canada in a variety of anti-aging cosmetic, dietary supplement and advanced DNA care products.

Daniel Zwiren, president and CEO of Optigenex Inc. said, “We are excited to add Suracell to our family of customers. We believe Suracell’s scientifically validated formulas are an ideal fit for the unique properties of AC-11(R), including natural DNA repair, immune enhancement and inhibition of pro-inflammatory agents. The licensing relationship we are entering into today will allow both companies to expand significantly their respective businesses and market penetration.

A Suracell spokesperson added, “The addition of AC -11(R) to the proprietary customized Suracell formulations gives us a product line unparalleled in its potential benefits to its customers. The evolving science surrounding AC 11(R) promises a very exciting future for our product offerings.

About Suracell Inc.:

Suracell Inc. provides personal genetic health programs formulated to measure, assess treat and monitor the body’s individual genetic needs. The testing and analysis programs are designed to pinpoint deficiencies and damage in an individual’s DNA and provide personalized recommended protocols consisting of specially formulated nutraceuticals and positive lifestyle choices.

About Optigenex Inc.:

Optigenex Inc. (www.optigenex.com) is a formulator, distributor and provider of proprietary next generation skin care, supplements and bulk ingredient featuring AC-11(R) (formerly known as C-MED-100(R)), a patented compound, as its core technology. AC- 11(R) is the bioactive, water-soluble form of the medicinal herb Uncaria tomentosa. For more information about Optigenex please email the company at: dzwiren@optigenex.com.

    * The statements made in this press release have not been evaluated by
        the Food and Drug Administration. The products mentioned in this
        release are not intended to diagnose, treat, cure or prevent any
        disease.

CONTACT: For more information about Optigenex please email the company at: dzwiren@optigenex.com

SOURCE Optigenex Inc.


Source: newswire



comments powered by Disqus